<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00417027</url>
  </required_header>
  <id_info>
    <org_study_id>0524-027</org_study_id>
    <nct_id>NCT00417027</nct_id>
  </id_info>
  <brief_title>Programmed Intermittent Epidural Bolus Time Interval and Injection Volume</brief_title>
  <official_title>Effect of Manipulation of the Programmed Intermittent Bolus Time Interval and Injection Volume on Total Drug Use for Labor Epidural Analgesia: a Randomized Controlled Trial</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Northwestern University</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Northwestern University</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      Studies suggest that administration of maintenance epidural solutions as programmed or
      automated intermittent boluses, rather than continuous infusions, result in lower bupivacaine
      consumption, decreased need for manual boluses by the anesthesiologist, and greater patient
      satisfaction. In this technique, the epidural maintenance dose is administered as a bolus by
      the infusion pump at regular intervals instead of as a continuous infusion. However, the
      optimal combination of bolus volume and dosing interval has not been determined. At one end
      of the spectrum, a small volume and short bolus dose interval will likely behave like a
      continuous infusion. At the other end of the spectrum, a large volume and long bolus dose
      interval may lead to an increased incidence of breakthrough pain. The purpose of this
      randomized, double-blind trial was to determine how manipulation of the programmed
      intermittent time interval and volume influences total drug use, quality of analgesia, and
      patient satisfaction during maintenance of labor analgesia. We hypothesized that manipulation
      of the programmed intermittent bolus time interval and volume during the maintenance of
      epidural labor analgesia influences total drug use, quality of analgesia and patient
      satisfaction.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      Traditionally, neuraxial labor analgesia was maintained for the duration of labor with manual
      intermittent bolus injection of anesthetic by the anesthesiologist via an in-dwelling
      epidural catheter. During the last decade, there has been a transition to maintenance of
      analgesia with a continuous epidural infusion. Analgesia is maintained with fewer episodes of
      breakthrough pain and parturient satisfaction is increased. The anesthesiologists' workload
      is less. More recently, use of patient controlled epidural analgesia (PCEA) has become
      popular; usually a continuous infusion is supplemented by patient-activated bolus injections.

      Studies have compared the intermittent manual epidural bolus technique to continuous
      infusion, continuous infusion to PCEA without a background infusion, and PCEA with and
      without a background infusion. Studies vary in the epidural solution local anesthetic mass
      (volume and concentration), and lock-out intervals. The incidence and intensity of motor
      blockade is greater with continuous infusion compared to bolus administration of the same
      concentration/mass local anesthetic per unit time, whether the bolus is administered manually
      or by PCEA. Consumption of local anesthetic is less with bolus administration (manual or
      PCEA) compared to continuous infusion. Therefore, lower concentrations of local anesthetic
      are frequently used for continuous infusions.

      Current pump technology supports continuous epidural infusion, PCEA without a background
      infusion, and PCEA with a background infusion. Current pump technology does not support
      programmed intermittent bolus administration with or without supplemental PCEA. Further study
      in this area may motivate pump manufacturers to redesign their pumps to support this type of
      drug administration.

      The purpose of the study is to determine how manipulation of the programmed intermittent time
      interval and volume influences total drug use, quality of analgesia, and patient satisfaction
      during maintenance of labor analgesia.

      Eligible women were asked to participate shortly after admission to the Labor and Delivery
      Unit at Prentice Women's Hospital immediately following the routine preanesthetic interview.
      Informed, written consent was obtained. At the time of request for labor analgesia the cervix
      was examined and a baseline Visual Analog Scale (VAS) for pain (100 mm unmarked line with the
      end points labeled &quot;no pain&quot; and &quot;worst pain imaginable&quot;) was determined. Labor analgesia was
      initiated with a routine combined spinal epidural (CSE) technique. The VAS for pain was
      determined 10 minutes after the intrathecal injection. If the VAS was less than 10 mm, the
      parturient was randomized (by a computer generated random number table) to one of three
      programmed intermittent epidural bolus analgesia maintenance techniques: 2.5 mL every 15
      minutes, 5 mL every 30 minutes, or 10 mL every 60 minutes. All epidural solutions consisted
      of bupivacaine 0.0625% with fentanyl 1.95 micrograms/mL. The initial programmed intermittent
      bolus dose was initiated 30 minutes after the intrathecal injection in all groups.

      Programmed intermittent epidural doses were administered via a Hospira Gemstar infusion pump.
      A commercial pump that can be programmed to administer intermittent boluses and patient
      controlled boluses does not exist. Thus two pumps were prepared for each subject with the
      same epidural solution. One pump was programmed to administer the programmed intermittent
      boluses at a rate of 300 ml/hr at regular intervals. The second pump was programmed to
      administer the patient's controlled epidural analgesia.

      VAS scores for pain were determined every 120 minutes until complete cervical dilation
      beginning 60 minutes after the intrathecal injection. A modified Bromage score was determined
      every 120 minutes during the 1st stage of labor (0=no motor paralysis; 1=inability to raise
      extended leg, but able to move knee and foot; 2=inability to raise extended leg and to move
      knee, but able to move foot; 3=inability to raise extended leg or to move knee and foot).
      Sensory threshold to a rigid von Frye filament (pressure applied with the rigid tip until the
      subject reported feeling pressure at the thoracic dermatome of T12, T10, T7, and T4) was
      determined bilaterally at initiation of epidural and 3 hours after the intrathecal injection.
      Epidural infusion was discontinued shortly after delivery. Prior to discharge from the Labor
      and Delivery Unit the parturient was asked to mark her overall satisfaction with labor
      analgesia using a 100 mm unmarked line with the left end labeled &quot;not satisfied at all&quot; and
      the right end labeled &quot;extremely satisfied&quot;.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>August 2006</start_date>
  <completion_date type="Actual">April 2009</completion_date>
  <primary_completion_date type="Actual">March 2009</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>Randomized</allocation>
    <intervention_model>Parallel Assignment</intervention_model>
    <primary_purpose>Treatment</primary_purpose>
    <masking>Double (Participant, Investigator)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Total Bupivicaine in Milligrams Administered Per Hour of Labor for Analgesia.</measure>
    <time_frame>From initiation of labor analgesia until delivery less than 24 hours</time_frame>
    <description>Total bupivacaine from epidural solution administered for labor analgesia normalized per hour of labor.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Area Under the Visual Analog Pain Scores (0 to 100mm) Per Hour of Labor Analgesia Curve</measure>
    <time_frame>Duration of labor analgesia</time_frame>
    <description>The pain burden calculated as the area under the visual analog pain scale (0 to 100 mm) patient self reported assessment of pain. Pain assessment were made at regular intervals during labor and the area under the pain score per time curve was calculated as the pain burden during labor. Greater pain would be indicated by a larger area. Possible range would be 0 for no pain to 100 for severe pain.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Patient Controlled Bolus Attempts</measure>
    <time_frame>Duration of labor analgesia</time_frame>
    <description>The number of attempted self administered bolus doses of epidural analgesia solution for control of pain.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Number of Patient Controlled Bolus Doses of Bupivacaine/Fentanyl Administered</measure>
    <time_frame>Duration of labor analgesia</time_frame>
    <description>Patient controlled bolus of analgesic solution could be requested by activating a button. Bolus were 5ml of the epidural solution (bupivacaine 6.25mg/ml and fentanyl 1.96mgml). Patient requested administrations were allowed every 10 minutes to a maximum of 30 ml of epidural solution per hour.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Manual Bolus Doses Administered</measure>
    <time_frame>Duration of labor analgesia</time_frame>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Highest Thoracic Dermatome Sensory Level to Ice. Higher Levels Are Given by Lower Thoracic Vertebral Number.</measure>
    <time_frame>3 hours after initiation of labor analgesia</time_frame>
    <description>Highest level of sensory loss to ice 3 hours after initiation of epidural analgesia. Thoracic dermatomes specify the level at which the nerves exit the spinal column. Higher thoracic spread of analgesia suggests greater dispersion of the epidural solution and may correlate with better analgesia. Higher levels are given by lower thoracic vertebral number. For example dermatome 4 has greater spread than dermatome 5.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Overall Satisfaction Scores. Higher Scores Represent Greater Satisfaction With Analgesia During Labor and Delivery.</measure>
    <time_frame>24 hours following labor analgesia</time_frame>
    <description>Patient satisfaction with analgesia management during labor and delivery. Scores are 0 to 100 with 0 complete dissatisfaction and 100 complete satisfaction with labor analgesia.</description>
  </secondary_outcome>
  <number_of_arms>3</number_of_arms>
  <enrollment type="Actual">190</enrollment>
  <condition>Labor Pain</condition>
  <arm_group>
    <arm_group_label>2.5 mL bolused every 15 minutes</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>5ml bolused every 30 minutes</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <arm_group>
    <arm_group_label>10ml bolused every 60 minutes</arm_group_label>
    <arm_group_type>Active Comparator</arm_group_type>
  </arm_group>
  <intervention>
    <intervention_type>Procedure</intervention_type>
    <intervention_name>Programmed Intermittent Epidural Bolus (PIEB)</intervention_name>
    <description>A commercial pump that can be programmed to administer intermittent boluses and patient controlled boluses does not exist. Two pumps were prepared for each subject with the same epidural solution. One pump was programmed to administer the programmed intermittent epidural bolus(PIEB). The second pump was programmed to administer patient controlled epidural analgesia (PCEA)with a dose of 5 mL delivered with a lockout of every 10 minutes.</description>
    <arm_group_label>2.5 mL bolused every 15 minutes</arm_group_label>
    <arm_group_label>5ml bolused every 30 minutes</arm_group_label>
    <arm_group_label>10ml bolused every 60 minutes</arm_group_label>
    <other_name>Hospira Gemstar infusion pump</other_name>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  Healthy

          -  nulliparous women

          -  term gestation (greater than or equal to 37 weeks gestation)

          -  spontaneous labor or with spontaneous rupture of membranes

        Exclusion Criteria:

          -  Systemic disease (e.g., diabetes mellitus, hypertension, preeclampsia)

          -  use of chronic analgesic medications

          -  systemic opioid labor analgesia prior to the initiation of neuraxial labor analgesia

          -  cervical dilation less than 2cm or greater than 5cm at time of initiation of neuraxial
             analgesia

          -  delivery within 90 minutes of intrathecal injection
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>45 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Cynthia A Wong, M.D.</last_name>
    <role>Principal Investigator</role>
    <affiliation>Northwestern University</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Northwestern Memorial Hospital</name>
      <address>
        <city>Chicago</city>
        <state>Illinois</state>
        <zip>60611</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <reference>
    <citation>Paech MJ, Pavy TJ, Sims C, Westmore MD, Storey JM, White C. Clinical experience with patient-controlled and staff-administered intermittent bolus epidural analgesia in labour. Anaesth Intensive Care. 1995 Aug;23(4):459-63.</citation>
    <PMID>7485937</PMID>
  </reference>
  <reference>
    <citation>Boutros A, Blary S, Bronchard R, Bonnet F. Comparison of intermittent epidural bolus, continuous epidural infusion and patient controlled-epidural analgesia during labor. Int J Obstet Anesth. 1999 Oct;8(4):236-41.</citation>
    <PMID>15321117</PMID>
  </reference>
  <reference>
    <citation>Bogod DG, Rosen M, Rees GA. Extradural infusion of 0.125% bupivacaine at 10 ml h-1 to women during labour. Br J Anaesth. 1987 Mar;59(3):325-30.</citation>
    <PMID>3828182</PMID>
  </reference>
  <reference>
    <citation>Smedstad KG, Morison DH. A comparative study of continuous and intermittent epidural analgesia for labour and delivery. Can J Anaesth. 1988 May;35(3 ( Pt 1)):234-41.</citation>
    <PMID>3289768</PMID>
  </reference>
  <reference>
    <citation>van der Vyver M, Halpern S, Joseph G. Patient-controlled epidural analgesia versus continuous infusion for labour analgesia: a meta-analysis. Br J Anaesth. 2002 Sep;89(3):459-65. Review.</citation>
    <PMID>12402726</PMID>
  </reference>
  <reference>
    <citation>Paech MJ. Patient-controlled epidural analgesia in labour--is a continuous infusion of benefit? Anaesth Intensive Care. 1992 Feb;20(1):15-20.</citation>
    <PMID>1609935</PMID>
  </reference>
  <reference>
    <citation>Ferrante FM, Rosinia FA, Gordon C, Datta S. The role of continuous background infusions in patient-controlled epidural analgesia for labor and delivery. Anesth Analg. 1994 Jul;79(1):80-4.</citation>
    <PMID>8010458</PMID>
  </reference>
  <reference>
    <citation>Boselli E, Debon R, Cimino Y, Rimmelé T, Allaouchiche B, Chassard D. Background infusion is not beneficial during labor patient-controlled analgesia with 0.1% ropivacaine plus 0.5 microg/ml sufentanil. Anesthesiology. 2004 Apr;100(4):968-72.</citation>
    <PMID>15087635</PMID>
  </reference>
  <reference>
    <citation>Petry J, Vercauteren M, Van Mol I, Van Houwe P, Adriaensen HA. Epidural PCA with bupivacaine 0.125%, sufentanil 0.75 microgram and epinephrine 1/800.000 for labor analgesia: is a background infusion beneficial? Acta Anaesthesiol Belg. 2000;51(3):163-6.</citation>
    <PMID>11129615</PMID>
  </reference>
  <reference>
    <citation>Halonen P, Sarvela J, Saisto T, Soikkeli A, Halmesmäki E, Korttila K. Patient-controlled epidural technique improves analgesia for labor but increases cesarean delivery rate compared with the intermittent bolus technique. Acta Anaesthesiol Scand. 2004 Jul;48(6):732-7.</citation>
    <PMID>15196106</PMID>
  </reference>
  <reference>
    <citation>Chua SM, Sia AT. Automated intermittent epidural boluses improve analgesia induced by intrathecal fentanyl during labour. Can J Anaesth. 2004 Jun-Jul;51(6):581-5.</citation>
    <PMID>15197122</PMID>
  </reference>
  <reference>
    <citation>Ueda K, Ueda W, Manabe M. A comparative study of sequential epidural bolus technique and continuous epidural infusion. Anesthesiology. 2005 Jul;103(1):126-9.</citation>
    <PMID>15983464</PMID>
  </reference>
  <reference>
    <citation>Hogan Q. Distribution of solution in the epidural space: examination by cryomicrotome section. Reg Anesth Pain Med. 2002 Mar-Apr;27(2):150-6.</citation>
    <PMID>11915061</PMID>
  </reference>
  <reference>
    <citation>Chestnut DH, Owen CL, Bates JN, Ostman LG, Choi WW, Geiger MW. Continuous infusion epidural analgesia during labor: a randomized, double-blind comparison of 0.0625% bupivacaine/0.0002% fentanyl versus 0.125% bupivacaine. Anesthesiology. 1988 May;68(5):754-9.</citation>
    <PMID>3285732</PMID>
  </reference>
  <reference>
    <citation>Li DF, Rees GA, Rosen M. Continuous extradural infusion of 0.0625% or 0.125% bupivacaine for pain relief in primigravid labour. Br J Anaesth. 1985 Mar;57(3):264-70.</citation>
    <PMID>3978008</PMID>
  </reference>
  <reference>
    <citation>Bernard JM, Le Roux D, Vizquel L, Barthe A, Gonnet JM, Aldebert A, Benani RM, Fossat C, Frouin J. Patient-controlled epidural analgesia during labor: the effects of the increase in bolus and lockout interval. Anesth Analg. 2000 Feb;90(2):328-32.</citation>
    <PMID>10648316</PMID>
  </reference>
  <reference>
    <citation>Gambling DR, Huber CJ, Berkowitz J, Howell P, Swenerton JE, Ross PL, Crochetière CT, Pavy TJ. Patient-controlled epidural analgesia in labour: varying bolus dose and lockout interval. Can J Anaesth. 1993 Mar;40(3):211-7.</citation>
    <PMID>8467542</PMID>
  </reference>
  <verification_date>March 2014</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 27, 2006</study_first_submitted>
  <study_first_submitted_qc>December 27, 2006</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 28, 2006</study_first_posted>
  <results_first_submitted>June 28, 2011</results_first_submitted>
  <results_first_submitted_qc>November 6, 2011</results_first_submitted_qc>
  <results_first_posted type="Estimate">December 9, 2011</results_first_posted>
  <last_update_submitted>March 17, 2014</last_update_submitted>
  <last_update_submitted_qc>March 17, 2014</last_update_submitted_qc>
  <last_update_posted type="Estimate">April 14, 2014</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Northwestern University</investigator_affiliation>
    <investigator_full_name>Cynthia Wong</investigator_full_name>
    <investigator_title>Professor of Anesthesiology</investigator_title>
  </responsible_party>
  <keyword>Patient controlled epidural analgesia</keyword>
  <keyword>Labor analgesia</keyword>
  <keyword>Epidural analgesia</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Labor Pain</mesh_term>
  </condition_browse>

  <clinical_results>

    <participant_flow>
      <recruitment_details>Nulliparous women in spontaneous labor were asked to participate shortly after admission to the Labor and Delivery Unit at Prentice Women's Hospital. Immediately following the routine preanesthetic interview, subjects were approached and informed, written consent was obtained.</recruitment_details>
      <group_list>
        <group group_id="P1">
          <title>2.5 mL Bolused Every 15 Minutes</title>
          <description>Laboring women receiving a programmed intermittent epidural bolus of 2.5 ml of bupivacaine 6.25 mg/ml and fentanyl 1.96 mcg/ml every 15 minutes. Patients could request additional 5 ml of the solution via a patient controlled administration every 15 minutes to a maximum of 30ml per hour.</description>
        </group>
        <group group_id="P2">
          <title>5ml Bolused Every 30 Minutes</title>
          <description>Laboring women receiving a programmed intermittent epidural bolus of 5 ml of bupivacaine 6.25 mg/ml and fentanyl 1.96 mcg/ml every 30 minutes. Patients could request additional 5 ml of the solution via a patient controlled activation to a maximum of 30 ml per hour.</description>
        </group>
        <group group_id="P3">
          <title>10ml Bolused Every 60 Minutes</title>
          <description>Laboring women receiving a programmed intermittent epidural bolus of 10 ml of bupivacaine 6.25 mg/ml and fentanyl 1.96 mcg/ml every 60 minutes. Patients could request additional 5 ml of the solution via a patient controlled activation to a maximum of 30 ml per hour.</description>
        </group>
      </group_list>
      <period_list>
        <period>
          <title>Overall Study</title>
          <milestone_list>
            <milestone>
              <title>STARTED</title>
              <participants_list>
                <participants group_id="P1" count="66"/>
                <participants group_id="P2" count="65"/>
                <participants group_id="P3" count="59"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="66"/>
                <participants group_id="P2" count="60"/>
                <participants group_id="P3" count="54"/>
              </participants_list>
            </milestone>
            <milestone>
              <title>NOT COMPLETED</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="5"/>
                <participants group_id="P3" count="5"/>
              </participants_list>
            </milestone>
          </milestone_list>
          <drop_withdraw_reason_list>
            <drop_withdraw_reason>
              <title>Protocol Violation</title>
              <participants_list>
                <participants group_id="P1" count="0"/>
                <participants group_id="P2" count="5"/>
                <participants group_id="P3" count="5"/>
              </participants_list>
            </drop_withdraw_reason>
          </drop_withdraw_reason_list>
        </period>
      </period_list>
    </participant_flow>

    <baseline>
      <group_list>
        <group group_id="B1">
          <title>2.5 mL Bolused Every 15 Minutes</title>
          <description>Laboring women receiving a programmed intermittent epidural bolus of 2.5 ml of bupivacaine 6.25 mg/ml and fentanyl 1.96 mcg/ml every 15 minutes. Patients could request additional 5 ml of the solution via a patient controlled administration every 15 minutes to a maximum of 30ml per hour.</description>
        </group>
        <group group_id="B2">
          <title>5ml Bolused Every 30 Minutes</title>
          <description>Laboring women receiving a programmed intermittent epidural bolus of 5 ml of bupivacaine 6.25 mg/ml and fentanyl 1.96 mcg/ml every 30 minutes. Patients could request additional 5 ml of the solution via a patient controlled activation to a maximum of 30 ml per hour.</description>
        </group>
        <group group_id="B3">
          <title>10ml Bolused Every 60 Minutes</title>
          <description>Laboring women receiving a programmed intermittent epidural bolus of 10 ml of bupivacaine 6.25 mg/ml and fentanyl 1.96 mcg/ml every 60 minutes. Patients could request additional 5 ml of the solution via a patient controlled activation to a maximum of 30 ml per hour.</description>
        </group>
        <group group_id="B4">
          <title>Total</title>
          <description>Total of all reporting groups</description>
        </group>
      </group_list>
      <analyzed_list>
        <analyzed>
          <units>Participants</units>
          <scope>Overall</scope>
          <count_list>
            <count group_id="B1" value="66"/>
            <count group_id="B2" value="65"/>
            <count group_id="B3" value="59"/>
            <count group_id="B4" value="190"/>
          </count_list>
        </analyzed>
      </analyzed_list>
      <measure_list>
        <measure>
          <title>Age</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>&lt;=18 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Between 18 and 65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="66"/>
                    <measurement group_id="B2" value="65"/>
                    <measurement group_id="B3" value="59"/>
                    <measurement group_id="B4" value="190"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>&gt;=65 years</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Age</title>
          <units>years</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="31" lower_limit="28" upper_limit="33"/>
                    <measurement group_id="B2" value="30" lower_limit="27" upper_limit="33"/>
                    <measurement group_id="B3" value="31" lower_limit="28" upper_limit="34"/>
                    <measurement group_id="B4" value="31" lower_limit="28" upper_limit="33"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Gender</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>Female</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="66"/>
                    <measurement group_id="B2" value="65"/>
                    <measurement group_id="B3" value="59"/>
                    <measurement group_id="B4" value="190"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Male</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="0"/>
                    <measurement group_id="B2" value="0"/>
                    <measurement group_id="B3" value="0"/>
                    <measurement group_id="B4" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <measure>
          <title>Region of Enrollment</title>
          <units>participants</units>
          <param>Number</param>
          <class_list>
            <class>
              <title>United States</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="B1" value="66"/>
                    <measurement group_id="B2" value="65"/>
                    <measurement group_id="B3" value="59"/>
                    <measurement group_id="B4" value="190"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
      </measure_list>
    </baseline>

    <outcome_list>
      <outcome>
        <type>Primary</type>
        <title>Total Bupivicaine in Milligrams Administered Per Hour of Labor for Analgesia.</title>
        <description>Total bupivacaine from epidural solution administered for labor analgesia normalized per hour of labor.</description>
        <time_frame>From initiation of labor analgesia until delivery less than 24 hours</time_frame>
        <population>per protocal</population>
        <group_list>
          <group group_id="O1">
            <title>2.5 mL Bolused Every 15 Minutes</title>
            <description>Laboring women receiving a programmed intermittent epidural bolus of 2.5 ml of bupivacaine 6.25 mg/ml and fentanyl 1.96 mcg/ml every 15 minutes. Patients could request additional 5 ml of the solution via a patient controlled administration every 15 minutes to a maximum of 30ml per hour.</description>
          </group>
          <group group_id="O2">
            <title>5ml Bolused Every 30 Minutes</title>
            <description>Laboring women receiving a programmed intermittent epidural bolus of 5 ml of bupivacaine 6.25 mg/ml and fentanyl 1.96 mcg/ml every 30 minutes. Patients could request additional 5 ml of the solution via a patient controlled activation to a maximum of 30 ml per hour.</description>
          </group>
          <group group_id="O3">
            <title>10ml Bolused Every 60 Minutes</title>
            <description>Laboring women receiving a programmed intermittent epidural bolus of 10 ml of bupivacaine 6.25 mg/ml and fentanyl 1.96 mcg/ml every 60 minutes. Patients could request additional 5 ml of the solution via a patient controlled activation to a maximum of 30 ml per hour.</description>
          </group>
        </group_list>
        <measure>
          <title>Total Bupivicaine in Milligrams Administered Per Hour of Labor for Analgesia.</title>
          <description>Total bupivacaine from epidural solution administered for labor analgesia normalized per hour of labor.</description>
          <population>per protocal</population>
          <units>mg bupivacaine per hour</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="66"/>
                <count group_id="O2" value="60"/>
                <count group_id="O3" value="54"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11.3" lower_limit="9.5" upper_limit="13.6"/>
                    <measurement group_id="O2" value="11.1" lower_limit="9.2" upper_limit="13.3"/>
                    <measurement group_id="O3" value="10.3" lower_limit="8.9" upper_limit="11.2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>&gt;0.05</p_value>
            <p_value_desc>Bonferroni corrected for 6 comparisons</p_value_desc>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.005</p_value>
            <p_value_desc>Bonferroni corrected for 6 comparisons</p_value_desc>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
          <analysis>
            <group_id_list>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.02</p_value>
            <p_value_desc>Bonferroni corrected for 6 comparisons</p_value_desc>
            <method>Wilcoxon (Mann-Whitney)</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Area Under the Visual Analog Pain Scores (0 to 100mm) Per Hour of Labor Analgesia Curve</title>
        <description>The pain burden calculated as the area under the visual analog pain scale (0 to 100 mm) patient self reported assessment of pain. Pain assessment were made at regular intervals during labor and the area under the pain score per time curve was calculated as the pain burden during labor. Greater pain would be indicated by a larger area. Possible range would be 0 for no pain to 100 for severe pain.</description>
        <time_frame>Duration of labor analgesia</time_frame>
        <population>per protocal</population>
        <group_list>
          <group group_id="O1">
            <title>2.5 mL Bolused Every 15 Minutes</title>
            <description>Laboring women receiving a programmed intermittent epidural bolus of 2.5 ml of bupivacaine 6.25 mg/ml and fentanyl 1.96 mcg/ml every 15 minutes. Patients could request additional 5 ml of the solution via a patient controlled administration every 15 minutes to a maximum of 30ml per hour.</description>
          </group>
          <group group_id="O2">
            <title>5ml Bolused Every 30 Minutes</title>
            <description>Laboring women receiving a programmed intermittent epidural bolus of 5 ml of bupivacaine 6.25 mg/ml and fentanyl 1.96 mcg/ml every 30 minutes. Patients could request additional 5 ml of the solution via a patient controlled activation to a maximum of 30 ml per hour.</description>
          </group>
          <group group_id="O3">
            <title>10ml Bolused Every 60 Minutes</title>
            <description>Laboring women receiving a programmed intermittent epidural bolus of 10 ml of bupivacaine 6.25 mg/ml and fentanyl 1.96 mcg/ml every 60 minutes. Patients could request additional 5 ml of the solution via a patient controlled activation to a maximum of 30 ml per hour.</description>
          </group>
        </group_list>
        <measure>
          <title>Area Under the Visual Analog Pain Scores (0 to 100mm) Per Hour of Labor Analgesia Curve</title>
          <description>The pain burden calculated as the area under the visual analog pain scale (0 to 100 mm) patient self reported assessment of pain. Pain assessment were made at regular intervals during labor and the area under the pain score per time curve was calculated as the pain burden during labor. Greater pain would be indicated by a larger area. Possible range would be 0 for no pain to 100 for severe pain.</description>
          <population>per protocal</population>
          <units>0 to 100 mm per hour</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="66"/>
                <count group_id="O2" value="60"/>
                <count group_id="O3" value="54"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="15" lower_limit="6" upper_limit="29"/>
                    <measurement group_id="O2" value="13" lower_limit="5" upper_limit="26"/>
                    <measurement group_id="O3" value="14" lower_limit="8" upper_limit="25"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.54</p_value>
            <method>Kruskal-Wallis</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Patient Controlled Bolus Attempts</title>
        <description>The number of attempted self administered bolus doses of epidural analgesia solution for control of pain.</description>
        <time_frame>Duration of labor analgesia</time_frame>
        <population>per protocal</population>
        <group_list>
          <group group_id="O1">
            <title>2.5 mL Bolused Every 15 Minutes</title>
            <description>Laboring women receiving a programmed intermittent epidural bolus of 2.5 ml of bupivacaine 6.25 mg/ml and fentanyl 1.96 mcg/ml every 15 minutes. Patients could request additional 5 ml of the solution via a patient controlled administration every 15 minutes to a maximum of 30ml per hour.</description>
          </group>
          <group group_id="O2">
            <title>5ml Bolused Every 30 Minutes</title>
            <description>Laboring women receiving a programmed intermittent epidural bolus of 5 ml of bupivacaine 6.25 mg/ml and fentanyl 1.96 mcg/ml every 30 minutes. Patients could request additional 5 ml of the solution via a patient controlled activation to a maximum of 30 ml per hour.</description>
          </group>
          <group group_id="O3">
            <title>10ml Bolused Every 60 Minutes</title>
            <description>Laboring women receiving a programmed intermittent epidural bolus of 10 ml of bupivacaine 6.25 mg/ml and fentanyl 1.96 mcg/ml every 60 minutes. Patients could request additional 5 ml of the solution via a patient controlled activation to a maximum of 30 ml per hour.</description>
          </group>
        </group_list>
        <measure>
          <title>Patient Controlled Bolus Attempts</title>
          <description>The number of attempted self administered bolus doses of epidural analgesia solution for control of pain.</description>
          <population>per protocal</population>
          <units>number of bolus attempts</units>
          <param>Mean</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="66"/>
                <count group_id="O2" value="60"/>
                <count group_id="O3" value="54"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10" lower_limit="3" upper_limit="17"/>
                    <measurement group_id="O2" value="10" lower_limit="3" upper_limit="17"/>
                    <measurement group_id="O3" value="8" lower_limit="4" upper_limit="11"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.32</p_value>
            <method>Kruskal-Wallis</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Number of Patient Controlled Bolus Doses of Bupivacaine/Fentanyl Administered</title>
        <description>Patient controlled bolus of analgesic solution could be requested by activating a button. Bolus were 5ml of the epidural solution (bupivacaine 6.25mg/ml and fentanyl 1.96mgml). Patient requested administrations were allowed every 10 minutes to a maximum of 30 ml of epidural solution per hour.</description>
        <time_frame>Duration of labor analgesia</time_frame>
        <population>per protocal</population>
        <group_list>
          <group group_id="O1">
            <title>2.5 mL Bolused Every 15 Minutes</title>
            <description>Laboring women receiving a programmed intermittent epidural bolus of 2.5 ml of bupivacaine 6.25 mg/ml and fentanyl 1.96 mcg/ml every 15 minutes. Patients could request additional 5 ml of the solution via a patient controlled administration every 15 minutes to a maximum of 30ml per hour.</description>
          </group>
          <group group_id="O2">
            <title>5ml Bolused Every 30 Minutes</title>
            <description>Laboring women receiving a programmed intermittent epidural bolus of 5 ml of bupivacaine 6.25 mg/ml and fentanyl 1.96 mcg/ml every 30 minutes. Patients could request additional 5 ml of the solution via a patient controlled activation to a maximum of 30 ml per hour.</description>
          </group>
          <group group_id="O3">
            <title>10ml Bolused Every 60 Minutes</title>
            <description>Laboring women receiving a programmed intermittent epidural bolus of 10 ml of bupivacaine 6.25 mg/ml and fentanyl 1.96 mcg/ml every 60 minutes. Patients could request additional 5 ml of the solution via a patient controlled activation to a maximum of 30 ml per hour.</description>
          </group>
        </group_list>
        <measure>
          <title>Number of Patient Controlled Bolus Doses of Bupivacaine/Fentanyl Administered</title>
          <description>Patient controlled bolus of analgesic solution could be requested by activating a button. Bolus were 5ml of the epidural solution (bupivacaine 6.25mg/ml and fentanyl 1.96mgml). Patient requested administrations were allowed every 10 minutes to a maximum of 30 ml of epidural solution per hour.</description>
          <population>per protocal</population>
          <units>participants</units>
          <param>Mean</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="66"/>
                <count group_id="O2" value="60"/>
                <count group_id="O3" value="54"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="7" lower_limit="3" upper_limit="11"/>
                    <measurement group_id="O2" value="6" lower_limit="4" upper_limit="10"/>
                    <measurement group_id="O3" value="6" lower_limit="4" upper_limit="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.69</p_value>
            <method>Kruskal-Wallis</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Manual Bolus Doses Administered</title>
        <time_frame>Duration of labor analgesia</time_frame>
        <group_list>
          <group group_id="O1">
            <title>2.5 mL Bolused Every 15 Minutes</title>
            <description>Laboring women receiving a programmed intermittent epidural bolus of 2.5 ml of bupivacaine 6.25 mg/ml and fentanyl 1.96 mcg/ml every 15 minutes. Patients could request additional 5 ml of the solution via a patient controlled administration every 15 minutes to a maximum of 30ml per hour.</description>
          </group>
          <group group_id="O2">
            <title>5ml Bolused Every 30 Minutes</title>
            <description>Laboring women receiving a programmed intermittent epidural bolus of 5 ml of bupivacaine 6.25 mg/ml and fentanyl 1.96 mcg/ml every 30 minutes. Patients could request additional 5 ml of the solution via a patient controlled activation to a maximum of 30 ml per hour.</description>
          </group>
          <group group_id="O3">
            <title>10ml Bolused Every 60 Minutes</title>
            <description>Laboring women receiving a programmed intermittent epidural bolus of 10 ml of bupivacaine 6.25 mg/ml and fentanyl 1.96 mcg/ml every 60 minutes. Patients could request additional 5 ml of the solution via a patient controlled activation to a maximum of 30 ml per hour.</description>
          </group>
        </group_list>
        <measure>
          <title>Manual Bolus Doses Administered</title>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="66"/>
                <count group_id="O2" value="60"/>
                <count group_id="O3" value="54"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>0 doses</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="24"/>
                    <measurement group_id="O2" value="30"/>
                    <measurement group_id="O3" value="27"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>1 dose</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="23"/>
                    <measurement group_id="O2" value="17"/>
                    <measurement group_id="O3" value="17"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>2 doses</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="12"/>
                    <measurement group_id="O2" value="11"/>
                    <measurement group_id="O3" value="7"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>3 doses</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="3"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="1"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>4 doses</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="4"/>
                    <measurement group_id="O2" value="1"/>
                    <measurement group_id="O3" value="2"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <groups_desc>Analysis apply to all rows. Only 1 comparison was made between the groups in distribution of number of bolus doses.</groups_desc>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.72</p_value>
            <p_value_desc>Analysis applies to all rows.</p_value_desc>
            <method>Chi-squared, Corrected</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Highest Thoracic Dermatome Sensory Level to Ice. Higher Levels Are Given by Lower Thoracic Vertebral Number.</title>
        <description>Highest level of sensory loss to ice 3 hours after initiation of epidural analgesia. Thoracic dermatomes specify the level at which the nerves exit the spinal column. Higher thoracic spread of analgesia suggests greater dispersion of the epidural solution and may correlate with better analgesia. Higher levels are given by lower thoracic vertebral number. For example dermatome 4 has greater spread than dermatome 5.</description>
        <time_frame>3 hours after initiation of labor analgesia</time_frame>
        <group_list>
          <group group_id="O1">
            <title>2.5 mL Bolused Every 15 Minutes</title>
            <description>Laboring women receiving a programmed intermittent epidural bolus of 2.5 ml of bupivacaine 6.25 mg/ml and fentanyl 1.96 mcg/ml every 15 minutes. Patients could request additional 5 ml of the solution via a patient controlled administration every 15 minutes to a maximum of 30ml per hour.</description>
          </group>
          <group group_id="O2">
            <title>5ml Bolused Every 30 Minutes</title>
            <description>Laboring women receiving a programmed intermittent epidural bolus of 5 ml of bupivacaine 6.25 mg/ml and fentanyl 1.96 mcg/ml every 30 minutes. Patients could request additional 5 ml of the solution via a patient controlled activation to a maximum of 30 ml per hour.</description>
          </group>
          <group group_id="O3">
            <title>10ml Bolused Every 60 Minutes</title>
            <description>Laboring women receiving a programmed intermittent epidural bolus of 10 ml of bupivacaine 6.25 mg/ml and fentanyl 1.96 mcg/ml every 60 minutes. Patients could request additional 5 ml of the solution via a patient controlled activation to a maximum of 30 ml per hour.</description>
          </group>
        </group_list>
        <measure>
          <title>Highest Thoracic Dermatome Sensory Level to Ice. Higher Levels Are Given by Lower Thoracic Vertebral Number.</title>
          <description>Highest level of sensory loss to ice 3 hours after initiation of epidural analgesia. Thoracic dermatomes specify the level at which the nerves exit the spinal column. Higher thoracic spread of analgesia suggests greater dispersion of the epidural solution and may correlate with better analgesia. Higher levels are given by lower thoracic vertebral number. For example dermatome 4 has greater spread than dermatome 5.</description>
          <units>participants</units>
          <param>Number</param>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="66"/>
                <count group_id="O2" value="60"/>
                <count group_id="O3" value="54"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <title>Thoracic dermatome 4</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6" lower_limit="7" upper_limit="4"/>
                    <measurement group_id="O2" value="5" lower_limit="7" upper_limit="5"/>
                    <measurement group_id="O3" value="5" lower_limit="7" upper_limit="5"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Thoracic dermatome 5</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="11" lower_limit="8" upper_limit="6"/>
                    <measurement group_id="O2" value="12" lower_limit="9" upper_limit="5"/>
                    <measurement group_id="O3" value="9" lower_limit="9" upper_limit="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Thoracic dermatome 6</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="9"/>
                    <measurement group_id="O2" value="7"/>
                    <measurement group_id="O3" value="8"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Thoracic dermatome 7</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="17"/>
                    <measurement group_id="O2" value="14"/>
                    <measurement group_id="O3" value="16"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Thoracic dermatome 8</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="10"/>
                    <measurement group_id="O2" value="8"/>
                    <measurement group_id="O3" value="6"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Thoracic dermatome 9</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="6"/>
                    <measurement group_id="O2" value="14"/>
                    <measurement group_id="O3" value="10"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
            <class>
              <title>Sensory level not tested</title>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="1"/>
                    <measurement group_id="O2" value="0"/>
                    <measurement group_id="O3" value="0"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.41</p_value>
            <method>Kruskal-Wallis</method>
          </analysis>
        </analysis_list>
      </outcome>
      <outcome>
        <type>Secondary</type>
        <title>Overall Satisfaction Scores. Higher Scores Represent Greater Satisfaction With Analgesia During Labor and Delivery.</title>
        <description>Patient satisfaction with analgesia management during labor and delivery. Scores are 0 to 100 with 0 complete dissatisfaction and 100 complete satisfaction with labor analgesia.</description>
        <time_frame>24 hours following labor analgesia</time_frame>
        <population>per protocal</population>
        <group_list>
          <group group_id="O1">
            <title>2.5 mL Bolused Every 15 Minutes</title>
            <description>Laboring women receiving a programmed intermittent epidural bolus of 2.5 ml of bupivacaine 6.25 mg/ml and fentanyl 1.96 mcg/ml every 15 minutes. Patients could request additional 5 ml of the solution via a patient controlled administration every 15 minutes to a maximum of 30ml per hour.</description>
          </group>
          <group group_id="O2">
            <title>5ml Bolused Every 30 Minutes</title>
            <description>Laboring women receiving a programmed intermittent epidural bolus of 5 ml of bupivacaine 6.25 mg/ml and fentanyl 1.96 mcg/ml every 30 minutes. Patients could request additional 5 ml of the solution via a patient controlled activation to a maximum of 30 ml per hour.</description>
          </group>
          <group group_id="O3">
            <title>10ml Bolused Every 60 Minutes</title>
            <description>Laboring women receiving a programmed intermittent epidural bolus of 10 ml of bupivacaine 6.25 mg/ml and fentanyl 1.96 mcg/ml every 60 minutes. Patients could request additional 5 ml of the solution via a patient controlled activation to a maximum of 30 ml per hour.</description>
          </group>
        </group_list>
        <measure>
          <title>Overall Satisfaction Scores. Higher Scores Represent Greater Satisfaction With Analgesia During Labor and Delivery.</title>
          <description>Patient satisfaction with analgesia management during labor and delivery. Scores are 0 to 100 with 0 complete dissatisfaction and 100 complete satisfaction with labor analgesia.</description>
          <population>per protocal</population>
          <units>Scores on a scale (0 toi 100)</units>
          <param>Median</param>
          <dispersion>Inter-Quartile Range</dispersion>
          <analyzed_list>
            <analyzed>
              <units>Participants</units>
              <scope>Measure</scope>
              <count_list>
                <count group_id="O1" value="66"/>
                <count group_id="O2" value="60"/>
                <count group_id="O3" value="54"/>
              </count_list>
            </analyzed>
          </analyzed_list>
          <class_list>
            <class>
              <category_list>
                <category>
                  <measurement_list>
                    <measurement group_id="O1" value="90" lower_limit="78" upper_limit="99"/>
                    <measurement group_id="O2" value="94" lower_limit="80" upper_limit="100"/>
                    <measurement group_id="O3" value="93" lower_limit="92" upper_limit="98"/>
                  </measurement_list>
                </category>
              </category_list>
            </class>
          </class_list>
        </measure>
        <analysis_list>
          <analysis>
            <group_id_list>
              <group_id>O1</group_id>
              <group_id>O2</group_id>
              <group_id>O3</group_id>
            </group_id_list>
            <non_inferiority_type>Superiority or Other</non_inferiority_type>
            <p_value>0.85</p_value>
            <method>Kruskal-Wallis</method>
          </analysis>
        </analysis_list>
      </outcome>
    </outcome_list>

    <reported_events>
      <group_list>
        <group group_id="E1">
          <title>2.5 mL Bolused Every 15 Minutes</title>
          <description>Laboring women receiving a programmed intermittent epidural bolus of 2.5 ml of bupivacaine 6.25 mg/ml and fentanyl 1.96 mcg/ml every 15 minutes. Patients could request additional 5 ml of the solution via a patient controlled administration every 15 minutes to a maximum of 30ml per hour.</description>
        </group>
        <group group_id="E2">
          <title>5ml Bolused Every 30 Minutes</title>
          <description>Laboring women receiving a programmed intermittent epidural bolus of 5 ml of bupivacaine 6.25 mg/ml and fentanyl 1.96 mcg/ml every 30 minutes. Patients could request additional 5 ml of the solution via a patient controlled activation to a maximum of 30 ml per hour.</description>
        </group>
        <group group_id="E3">
          <title>10ml Bolused Every 60 Minutes</title>
          <description>Laboring women receiving a programmed intermittent epidural bolus of 10 ml of bupivacaine 6.25 mg/ml and fentanyl 1.96 mcg/ml every 60 minutes. Patients could request additional 5 ml of the solution via a patient controlled activation to a maximum of 30 ml per hour.</description>
        </group>
      </group_list>
      <serious_events>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, serious adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="66"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </serious_events>
      <other_events>
        <frequency_threshold>0.10</frequency_threshold>
        <category_list>
          <category>
            <title>Total</title>
            <event_list>
              <event>
                <sub_title>Total, other adverse events</sub_title>
                <counts group_id="E1" subjects_affected="0" subjects_at_risk="66"/>
                <counts group_id="E2" subjects_affected="0" subjects_at_risk="60"/>
                <counts group_id="E3" subjects_affected="0" subjects_at_risk="54"/>
              </event>
            </event_list>
          </category>
        </category_list>
      </other_events>
    </reported_events>

    <certain_agreements>
      <pi_employee>All Principal Investigators ARE employed by the organization sponsoring the study.</pi_employee>
      <restrictive_agreement>There is NOT an agreement between Principal Investigators and the Sponsor (or its agents) that restricts the PI's rights to discuss or publish trial results after the trial is completed. </restrictive_agreement>
    </certain_agreements>
    <limitations_and_caveats>No group that received a continuous infusion or PCEA without a background infusion was included. Conclusions are limited to our patient population, drug concentrations, and mode of initiation of labor analgesia.</limitations_and_caveats>
    <point_of_contact>
      <name_or_title>Robert J. McCarthy, PharmD</name_or_title>
      <organization>Northwestern University Feinberg School of Medicine</organization>
      <phone>312-926-9015</phone>
      <email>r-mccarthy@northwestern.edu</email>
    </point_of_contact>
  </clinical_results>
</clinical_study>

